Chemical and physical parameters of tears relevant for the design of ocular drug delivery formulations

Pharmaceutica Acta Helvetiae

Volumn 72, Issue 4, 1997, Pages 191-202

  Baeyens, Vincent ^a   Gurny, Robert ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Ocular drug delivery; Ophthalmic formulation; Ophthalmology; Review; Tear; Tear sampling

Indexed keywords

ELECTROLYTE; TEAR PROTEIN;

ASSAY; CHEMICAL COMPOSITION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG FORMULATION; HUMAN; LACRIMAL FLUID; LACRIMAL GLAND; PHYSICAL PARAMETERS; REVIEW; SAMPLING;

ADMINISTRATION, TOPICAL; BUFFERS; CHEMISTRY, PHARMACEUTICAL; DRUG DESIGN; ELECTROLYTES; HUMANS; HYDROGEN-ION CONCENTRATION; OPHTHALMIC SOLUTIONS; TEARS;

EID: 0030662662     PISSN: 00316865     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-6865(97)00021-6     Document Type: Review

References (103)

1. Abelson, M.B. et al., 1980. Alkaline tear pH in ocular rosacea. Am. J. Ophthalmol. 90, 866-869.
2. Abelson, M.B. et al., 1981. Normal tear pH by direct measurement. Arch. Ophthalmol. 99, 301.
3. Attia, M.A. et al., 1988. In vivo performance of 3-H-dexamethasone ophthalmic film delivery system in the rabbit eye. Int. J. Pharm. 47, 21-30.
4. Baeyens, V. et al., 1997. Determination of dexamethasone in tears by capillary electrophoresis. J. Chromatogr. Biomed. Appl. 692, 222-226.
5. Barrera, R. et al., 1992. Evaluation of total protein content in tears of dogs by polyacrylamide gel disk electrophoresis. Am. J. Vet. Res. 53, 454-456.
6. Berta, A., 1983. Collection of tears samples with or without stimulation. Am. J. Ophthalmol. 96, 115-116.
7. Boonstra, A., Kijlstra, A., 1984. Separation of human tears proteins by HPLC. Curr. Eye Res. 3, 1461-1469.
8. Brogton, W.G., Dickinson, C.M., 1983. A microassay system for measuring esterase activity and protein concentration in small samples and in high-pressure liquid chromatography eluate fractions. Anal. Biochem. 131, 499-503.
9. Butty, P., 1995. Détermination in situ du pH et du pouvoir tampon de la surface cornéenne de la souris par épi-microscopie de fluorescence. Thèse Université de Genève, pp. 1-212.
10. Butty, P. et al., 1996. In situ determination of pH and buffer capacity of the mouse corneal surface using epi-microscopic fluorescence. Eur. J. Pharm. Biopharm. 42, 399-401.
11. Carney, L., Hill, R., 1976. Human tear pH. Arch. Ophthalmol. 94, 821-824.
12. Carney, L., Hill, R., 1979. Human tear buffering capacity. Arch. Ophthalmol. 97, 951-952.
13. Carney, L.G. et al., 1989. Buffering in human tears: pH responses to acid and base challenge. Invest. Ophthalmol. Vis. Sci. 30, 747-754.
14. Chadwick, R.R. et al., 1994. Applications of capillary electrophoresis in the eye-care pharmaceutical industry. J. Chromatogr. 671, 403-410.
15. Chen, F.S., Maurice, D.M., 1990. The pH in the precorneal tear film and under a contact lens measured with a fluorescent probe. Exp. Eye Res. 50, 251-259.
16. Chrai, S.S. et al., 1973. Lachrymal and instilled fluid dynamics in rabbit eyes. J. Pharm. Sci. 62, 1112-1121.
17. Coles, W., Jaros, P., 1984. Dynamics of ocular surface pH. Br. J. Ophthalmol. 68, 549-552.
18. Coyle, P.K. et al., 1989. Electrophoresis combined with immunologic identification of human tear proteins. Invest. Ophthalmol. Vis. Sci. 30, 1872-1878.
19. Coyle, P.K., Sibony, P.A., 1986. Tear immunoglobulins measured by ELISA. Invest. Ophthalmol. Vis. Sci. 27, 622-625.
20. Davidson, H.J. et al., 1992. Determination of protein concentrations and their molecular weight in tears from cats with normal corneas and cats with corneal sequestrum. Am. J. Vet. Res. 53, 1756-1759.
21. Davidson, H.J. et al., 1994. Comparison of tear proteins in the cow, horse, dog and rabbit. In: Sullivan, D.A. (Ed.), Lachrymal Gland, Tear Film, and Dry Eye Syndromes. Plenum Press, New York, pp. 331-334.
22. di Sant'Agnese, P.A. et al., 1958. Saliva, tears and duodenal contents in cystic fibrosis of the pancreas. Pediatrics 22, 507-514.
23. Ding, S. et al., 1992. Precorneal sampling techniques for ophthalmic gels. J. Ocular Pharmacol. 8 (2), 151-159.
24. Dumortier, G. et al., 1995. Dosage lachrymal: Méthodologie et applications biopharmaceutiques et cliniques. STP Pharma. 5, 503-510.
25. Feldman, J.B., 1937. pH and buffers in relation to ophthalmology. Arch. Ophthalmol. 17, 797-819.
26. Fischer, F., Wiederholt, M., 1982. Human precorneal tear film pH measured by microelectrodes. Graefe's Arch. Clin. Exp. Ophthalmol. 218, 168-170.
27. Fullard, R.J., 1988. Identification of proteins in small tear volumes with and without size exclusion HPLC fractionation. Curr. Eye Res. 7, 163-179.
28. Fullard, R.J., Kissner, D.M., 1991. Purification of the isoforms of tear specific prealbumin. Curr. Eye Res. 10, 613-628.
29. Fullard, R.J., Snyder, C., 1990. Protein levels in nonstimulated and stimulated tears of normal human subjects. Invest. Ophthalmol. Vis. Sci. 31, 1119-1126.
30. Fullard, R.J., Tucker, D.L., 1991. Changes in human tear protein levels with progressively increasing stimulus. Invest. Ophthalmol. Vis. Sci. 32, 2290-2301.
31. Gachon, A. et al., 1982. Human tears: Normal protein pattern and individual protein determinations in adults. Curr. Eye Res. 283, 301-308.
32. Gachon, A.M. et al., 1979. Immunological and electrophoretic studies of human tear proteins. Exp. Eye Res. 539-553.
33. Giardini, A., Roberts, J.R.E., 1950. Concentration of glucose and total chloride in tears. Br. J. Ophthalmol. 34, 737-743.
34. Grabner, G. et al., 1982. Human tear lysozyme: A comparison of electro-immunodiffusion, radial immunodiffusion and spectrophotometric assay. Graefe's Arch. Clin. Exp. Ophthalmol. 218, 265-270.
35. Grove-Rasmussen, K.V. et al., 1953. Some physical-chemical examinations of human lachrymal fluid. Acta Pharm. Int. 2, 343-359.
36. Hariton, C., Mandel, P., 1991. Ocular pharmacokinetics of calcium, chloride and sulfate ions after instillation in the rabbit. Biopharm. Drug Disposit. 12, 403-410.
37. Hill, R.M., Carney, L.G., 1980. Human tear responses to alkali. Invest. Ophthalmol. Vis. Sci. 19, 207-209.
38. Holly, F.J., 1973. Formation and stability of the tear film. Int. Ophthalmol. Clin. 13, 73-96.
39. Hudelo, A., Mergier, J., 1952. Etude du pH lacrymal, en fonction de l'état local et de l'état général. Ann. Ocul. 185, 764-771.
40. Huth, S.W. et al., 1980. Calcium in tears and contact lens wear. Arch. Ophthalmol. 98, 122-125.
41. Ibrahim, H. et al., 1988. Composition, structure et paramètres physiologiques du système lacrymal impliqués dans la conception de formes ophtalmiques. Pharm. Acta Helv. 63, 146-154.
42. Ibrahim, H., 1989. Concept et évaluation de systèmes polymériques dispersés (Pseudo-latex) à usage ophtalmique. Thèse Université de Genève.
43. Ibrahim, H. et al., 1991. Concept and development of pseudo-latexes triggered by pH. Int. J. Pharm. 77, 211-219.
44. Iwata, S., 1973. Chemical composition of the aqueous phase. Int. Ophthalmol. Clin. 13, 29-46.
45. Janssen, P.T., Van Bijsterveld, O.P., 1983. Origin and biosynthesis of human tear fluid proteins. Invest. Ophthalmol. Vis. Sci. 24, 623-630.
46. Lamberts, D.W., 1987. Basic science aspects: Physiology of the tear film. In: Smoli, G., Thoft, R.A. (Eds.), The Cornea: Scientific Foundations and Clinical Practice. Little, Brown and Company, Boston/Toronto, pp. 16-62.
47. Lee, V.H.L. et al., 1982. Esterase distribution in the rabbit cornea and its implications in ocular bioavailability. Biopharm. Drung Disposit. 3, 291-300.
48. Lee, V.H.L., 1983. Esterase activities in adult rabbit eyes. J. Pharm. Sci. 72, 239-244.
49. Lee, V.H.L. et al., 1985. Ocular esterase composition in albino rabbits: Possible implications in ocular prodrug design and evaluation. Curr. Eye Res. 4, 1117-1125.
50. Lee, V.H.L., 1993. Precorneal, corneal and postcorneal factors. In: Mitra, A.K. (Ed.), Ophthalmic drug delivery systems. Marcel Dekker, New York, pp. 59-81.
51. Lee, V.H.L., Bundgaard, H., 1992. Improved ocular delivery with prodrugs. In: Sloan, K.B. (Ed.), Prodrugs: Topical and Ocular Drug Delivery. Marcel Dekker, New York, pp. 221-297.
52. Lee, V.H.L., Carson, L.W., 1986. Ocular disposition of inulin from single and multiple doses of positively charged multilamellar liposomes: Evidence for alterations in tear dynamics and ocular surface characteristics. J. Ocular Pharmacol. 2, 353-364.
53. Lee, V.H.L., Robinson, J.R., 1986. Review: Topical ocular drug delivery: Recent developments and future challenges. J. Ocular Pharmacol. 2, 67-108.
54. Liotet, S. et al., 1982. Functional exploration of the lacrimal gland by tear electrophoresis. Ophthalmologica 184, 87-91.
55. Longwell, A. et al., 1976. Effect of topically applied pilocarpine on tear film pH. J. Pharm. Sci. 65, 1654-1657.
56. Lowry, O.H. et al., 1951. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193, 265-275.
57. Macdonald, E.A., Maurice, D.M., 1991. Loss of fluorescein across the conjunctiva. Exp. Eye Res. 53, 427-430.
58. Mandel, A.I. et al., 1978. Dipivalyl epinephrine: A new pro-drug in the treatment of glaucoma. Ophthalmology 85, 268-275.
59. Masters, B.R., Kino, O.S., 1992. Confocal microscopy of the eye. In: Master, B.R. (Ed.), Noninvasive Diagnostic Techniques in Ophthalmology. Springer-Verlag, New York, pp. 152-171.
60. Mastman, G.J. et al., 1961. The total osmotic pressure of tears in normal and various pathologic conditions. Arch. Ophthalmol. 65, 509-513.
61. Matthäus, W., 1962. Elektrometrische Messungen des pH-Wertes der Tränenflüssigkeit unter physiologischen und pathologischen Bedingungen. Klin. Mbl. Augenheilk. 141, 899-907.
62. Maurice, D.M., 1963. A new objective fluorophotometer. Exp. Eye Res. 2, 33-38.
63. Maurice, D.M., 1980. Structures and fluids involved in the penetration of topically applied drugs. Int. Ophthalmol. Clin. 20, 7-20.
64. McClellan, B.H. et al., 1973. Immunoglobulins in tears. Am. J. Ophthalmol. 76, 89-101.
65. McCollum, C.J. et al., 1994. Rapid assay of lactoferrin in keratoconjonctivis sicca. Cornea 13, 505-508.
66. Meijer, F., Van Haeringen, N.J., 1992. Comparison of three techniques for the determination of protein content in human tears. Clin. Chim. Acta 209, 209-214.
67. Meijer, F., Van Haeringen, N.J., 1993. Separation and characteristics of glycoproteins in tears which inhibit coating and precipitation of protein. Curr. Eye Res. 12, 531-538.
68. Mikkelson, T.J. et al., 1973. Altered bioavailability of drugs in the eye due to drug-protein interaction. J. Pharm. Sci. 62, 1648-1653.
69. Milder, B., 1987. The lacrimal apparatus. In: Moses, R.A., Hart, W.M.J. (Eds.), Adler's Physiology of the Eye, Clinical Application. The C.V. Mosby Company, St. Louis, pp. 15-35.
70. Mishima, S., 1965. Some physiological aspects of the precorneal tear film. Arch. Ophthalmol. 73, 233-241.
71. Mishima, S. et al., 1966. Determination of tear volume and tear flow. Invest. Ophthalmol. Vis. Sci. 5, 264-276.
72. Mishima, S., Maurice, D.M., 1961. The oily layer of the tear film and evaporation from the corneal surface. Exp. Eye Res. 1, 39-45.
73. Nicolaides, N. et al., 1981. Meibomian gland studies: Comparison of steer and human lipids. Invest. Ophthalmol. Vis. Sci. 20, 522-536.
74. Norn, M.S., 1968. Hydrogen ion concentration of tear fluid. Acta Ophthalmol. 46, 189-200.
75. Norn, M.S., 1985. Tear pH after instillation of buffer in vivo. Acta Ophthalmol. 65 (Suppl.), 32-34.
76. Norn, M.S., 1988. Tear fluid in normals, contact lens wearers, and pathological cases. Acta Ophthalmol. 66, 485-489.
77. Patton, T.F., Robinson, J.R., 1975. Ocular evaluation of polyvinyl alcohol vehicle in rabbits. J. Pharm. Sci. 64, 1312-1316.
78. Pedersen-Bjergaard, K., 1948. Hydrogen ion concentration of lachrymal fluid. Pharm. J. 106, 133.
79. Pedersen-Bjergaard, K., Smidt, B.C., 1952. Electrolytic conductivity, osmotic pressure, and hydrogen ion concentration of human lachrymal enzyme. Acta Derm. Venereol. Suppl. 32, 261-267.
80. Polanski, J.R., Weinreb, R.N., 1984. Anti-inflammatory agents: Steroids as anti-inflammatory agents. In: Sears, M.L. (Ed.), Pharmacology of the Eye. Spring-Verlag, Heildelberg, pp. 466-479.
81. Prydal, J.I. et al., 1992. Study of human precorneal tear film thickness and structure using laser interferometry. Invest. Ophthalmol. Vis. Sci. 33, 2006-2011.
82. Prydal, J.I., Campbell, F.W., 1992. Study of precorneal tear film thickness and structure by interferometry and confocal microscopy. Invest. Ophthalmol. Vis. Sci. 33, 1996-2005.
83. Rexed, U., 1958. The pH of the lachrymal fluid determined by a capillary micro-glass electrode. Acta Ophthalmol., 711-718.
84. Rolando, M., Refojo, M.F., 1983. Tear evaporimeter for measuring water evaporation rate from the tear film under controlled conditions in humans. Exp. Eye Res. 36, 25-33.
85. Royer, J. et al., 1982. Physiopathologie des larmes, le film lacrymal. In: Masson (Ed.), L'appareil Lacrymal. Masson, Paris, pp. 75-106.
86. Rozier, A. et al., 1989. Gelrite: A novel, ion-activated, in-situ gelling polymer for ophthalmic vehicles. Effect on bioavailability of timolol. Int. J. Pharm. 163-168.
87. Sack, R. et al., 1992. Diurnal tear cycle: Evidence for a nocturnal inflammatory constitutive tear fluid. Invest. Ophthalmol. Vis. Sci. 33, 626-640.
88. Selsted, M., Martinez, R.J., 1982. Isolation and purification of bactericides from human tears. Exp. Eye Res. 34, 305-318.
89. Sen, O.K., Sarin, O.S., 1980. Immunoassay of human tear lysozyme. Am. J. Ophthalmol. 90, 715-718.
90. Shopsis, C., MacKay, G.J., 1984. A semi-automated protein assay for cell cultures. Anal. Biochem. 140, 104-107.
91. Sorensen, T., 1975. Determination of tear flow using a radioactive tracer. Acta Ophthalmol. 125 (Suppl.), 43-44.
92. Splittgerber, A.C., Sohl, J., 1989. Nonlinearity in protein assays by the coomassie blue dye-binding method. Anal. Biochem. 179, 198-201.
93. Stuchell, R. et al., 1984. The effect of collection technique on tear composition. Invest. Ophthalmol. Vis. Sci. 25, 374-377.
94. Tan, K.O. et al., 1993. Temporal sequence of changes in tear film composition during sleep. Curr. Eye Res. 12, 1001-1007.
95. Thaysen, J.H., Thorn, N.A., 1954. Excretion of urea, sodium, potassium and chloride in human tears. Am. J. Physiol. 178, 160-164.
96. Tsubota, K., Yamada, M., 1992. Tear evaporation from the ocular surface. Invest. Ophthalmol. Vis. Sci. 33, 2942-2950.
97. Uotila, M.H. et al., 1972. Measurement of tear calcium levels. Am. J. Ophthalmol. 11, 258-259.
98. Van Haeringen, N., 1981. Clinical biochemistry of tears. Surv. Ophthalmol. 26, 84-96.
99. Van Haeringen, N.J., Glasius, E., 1974. Enzymatic studies in lacrimal secretion. Exp. Eye Res. 19, 135-139.
100. Van Haeringen, N.J., Kijltrat, A., 1991. SDS-minigel electrophoresis of human tears. Effect of sample treatment on protein patterns. Invest. Ophthalmol. Vis. Sci. 32, 381-386.
101. Vera, J.C., 1988. Measurement of microgram quantities of protein by a generally applicable turbidimetric procedure. Anal. Biochem. 174, 187-196.
102. Winder, A. et al., 1977. Tear calcium levels and contact lens wear. Br. J. Ophthalmol. 61, 539-543.
103. Zavaro, A. et al., 1980. Proteins in tears from healthy and diseased eyes. Doc. Ophthalmol. 50, 185-199.